Watchlist Price Alert

Taysha Gene Therapies Inc... (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

2.58

0.02 (0.78%)

At close: Jun 17, 2025, 3:59 PM

2.58

0.00%

After-hours: Jun 17, 2025, 05:28 PM EDT

Taysha Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-89.3M	-111.57M	-166.01M	-174.52M	-60.01M	-4.46M
Depreciation & Amortization	1.25M	1.37M	1.17M	492K	9K	n/a
Stock-Based Compensation	13.1M	7.91M	18.04M	18.18M	3.35M	n/a
Other Working Capital	-9.55M	-15.72M	26.32M	14.17M	-2.07M	540K
Other Non-Cash Items	6.19M	47.28M	39.89M	10.14M	26.03M	3.92M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-12.47M	-18.01M	18.52M	28.67M	-111K	540K
Operating Cash Flow	-81.22M	-73.02M	-88.39M	-117.04M	-30.73M	135K
Capital Expenditures	-374K	-7.37M	-24.87M	-21.55M	-9.08M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	11K	-3.48M	-61K	-6.25M	-9M	n/a
Investing Cash Flow	-363K	-7.35M	-24.93M	-21.55M	-9.08M	n/a
Debt Repayment	n/a	-3.45M	n/a	39.96M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-96K	-947K	-1.15M	-874K	n/a	n/a
Financial Cash Flow	76.68M	136.39M	52.1M	39.08M	291.06M	n/a
Net Cash Flow	-4.9M	56.02M	-61.22M	-99.51M	251.25M	135K
Free Cash Flow	-81.6M	-80.39M	-113.26M	-138.6M	-39.81M	135K